TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Cancers (Basel)
; 12(6)2020 Jun 11.
Article
in En
| MEDLINE
| ID: mdl-32545367
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2020
Document type:
Article
Affiliation country:
Australia
Country of publication:
Switzerland